Cite
HARVARD Citation
Aigner, E. et al. (2018). Benefit of Treatment With Sebelipase‐Alfa in a 63‐Year‐Old Patient With Advanced Liver and Atherosclerotic Disease Due to Lysosomal Acid Lipase Deficiency (LAL‐D). American journal of gastroenterology. p. . [Online].